Pulmonary hypertension study at high altitude
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how the heart and lungs respond when people with pulmonary hypertension travel from low to high altitude. It may help doctors understand how to better care for patients living at high altitudes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You live permanently above 2,600 meters (about 8,500 feet) altitude.
- You have been diagnosed with pulmonary arterial hypertension (PAH) and your condition is stable on your current treatment.
- You are in NYHA functional class I, II, or III (meaning you can do some activity without severe symptoms).
- You have not traveled to low altitude (below 2,000 meters) and stayed overnight in the past 4 weeks.
- You do not have severe lung disease, severe smoking (more than 20 cigarettes a day), or other serious heart, kidney, liver, or blood conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how the heart and lungs respond at high altitude versus sea level in people with pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs. It may help doctors understand if living at high altitude affects symptoms and treatment.
This study compares how well your lungs work when you are at high altitude (your home) versus when you visit sea level. It aims to understand how altitude affects people with pulmonary arterial hypertension, which is high blood pressure in the lungs.
This study looks at how your heart rate changes when you travel from high altitude (about 2850 meters) down to sea level and back up again. It may help doctors understand if such travel is safe for people with pulmonary hypertension.
This study compares sleep quality and breathing patterns in people with pulmonary arterial hypertension (PAH) who live at high altitude versus those at sea level. It aims to understand how altitude affects sleep in PAH, which could help improve care for patients living in high-altitude areas.
This study compares how far people with pulmonary arterial hypertension (PAH) can walk in six minutes at high altitude versus at sea level. Understanding this difference may help doctors better tailor care for patients living at high altitudes.
This study looks at how your heart and lungs handle the thin air at high altitudes compared to sea level. It aims to understand normal changes in blood pressure in your lungs, which may help people with certain heart or lung conditions.
Hear when a new Pulmonary Vascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.